Title: Yu-Chuan Huang: Innovator in Pharmaceutical Research
Introduction: Yu-Chuan Huang is a notable inventor based in Taipei, Taiwan. He is currently associated with Sinphar Tian-li Pharmaceutical Co., Ltd. Despite having no granted patents to his name, his contributions to pharmaceutical research are significant. His work focuses on developing innovative solutions for medical challenges.
Latest Patent Applications: Yu-Chuan Huang has been involved in several latest patent applications. One of his applications is titled "A Phage-Displayed Single-Chain Variable Fragment Library for Selecting Antibody Fragments Specific to Mesothelin." This application discloses a phage-displayed single-chain variable fragment (scFv) library, which comprises a plurality of phage-displayed scFvs characterized with a specific sequence in each CDR. The present phage-displayed scFv library is useful in selecting an antibody fragment exhibiting a binding affinity and specificity to mesothelin (MSLN). Additionally, it includes a recombinant antibody specific to MSLN, an immunoconjugate comprising the recombinant antibody, and uses thereof in treating cancers. Another application is titled "Recombinant Antibodies, Kits Comprising the Same, and Uses Thereof." This application discloses recombinant antibodies or fragments for detecting severe acute respiratory syndrome coronavirus (SARS-CoV). It includes a kit comprising the recombinant antibodies and a method for diagnosing the infection of SARS-CoV by using the recombinant antibody or the kit.
Conclusion: Yu-Chuan Huang's innovative work in pharmaceutical research, particularly in antibody development and viral detection, showcases his commitment to advancing medical science. His contributions, although not yet reflected in granted patents, hold promise for future breakthroughs in healthcare.